Lion Point Capital, LP Portfolio Holdings

Lion Point Capital, LP

  • $9.73 Million
  • Q1 2025

Lion Point Capital, LP has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $9.73 Million distributed in 21 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Insmed Inc with a value of $2.33M, Ardelyx, Inc. with a value of $1.65M, Fennec Pharmaceuticals Inc. with a value of $1.19M, Bridge Bio Pharma, Inc. with a value of $898K, and Geron Corp with a value of $795K.

Examining the 13F form we can see an decrease of $3.2M in the current position value, from $12.9M to 9.73M.

Lion Point Capital, LP is based out at New York, NY

Below you can find more details about Lion Point Capital, LP portfolio as well as his latest detailed transactions.

Portfolio value $9.73 Million
Healthcare: $9.73 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$13.8B
$2.33 Million 23.92% of portfolio
30,500
Q1 2025 Reduced 16.89%
$693M
$1.65 Million 16.93% of portfolio
335,400
Q4 2024 Reduced 9.35%
$224M
$1.19 Million 12.25% of portfolio
195,700
Q4 2024 Reduced 8.98%
$7.07B
$898,000 9.23% of portfolio
26,000
Q1 2025 Reduced 35.48%
$518M
$795,000 8.17% of portfolio
500,000
Q4 2024 Reduced 20.63%
$957M
$724,000 7.44% of portfolio
46,300
Q4 2024 Added 31.91%
$557M
$675,000 6.94% of portfolio
55,000
Q4 2024 Added 19.05%
$67.5M
$439,000 4.51% of portfolio
548,806
Q1 2025 Reduced 46.5%
$376M
$412,000 4.24% of portfolio
57,750
Q3 2024 Added 59.31%
$1.36B
$238,000 2.45% of portfolio
340,761
Q4 2023 Reduced 50.74%
$30.1M
$218,000 2.24% of portfolio
644,000
Q1 2025 New
$249M
$142,000 1.46% of portfolio
83,500
Q1 2025 New
$1.65M
$21,000 0.22% of portfolio
75,000
Q1 2024 New
Jasper Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 Added 357.81%
Kiniksa Pharmaceuticals LTD
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 25.24%
Avadel Pharmaceuticals PLC
-
$0 0.0% of portfolio
-
Q1 2025 Added 54.22%
Mineralys Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2024 Added 31.67%
Biohaven LTD
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 35.88%
Bluebird Bio Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Disc Medicine Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 37.66%

Summary

  • Portfolio
  • No. of Stocks 21
  • Current Value $9.73 Million
  • Prior Value $12.9 Million
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 2 stocks
  • Additional Purchases 2 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 3 stocks
Track This Portfolio

Track Lion Point Capital, LP Portfolio

Follow Lion Point Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lion Point Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Lion Point Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email